On September 5, 2022, Prestige Biologics Co., Ltd closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,830 KRW | +2.08% |
|
-0.79% | -6.86% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.86% | 75.45M | |
+2.08% | 95.18B | |
-0.13% | 37.55B | |
-10.58% | 33.75B | |
+77.76% | 28.2B | |
-14.85% | 15.63B | |
-3.38% | 13.63B | |
-12.76% | 11.5B | |
+181.73% | 10.81B | |
-53.92% | 9.23B |
- Stock Market
- Equities
- A950210 Stock
- News Prestige BioPharma Limited
- Prestige Biologics Co., Ltd. announced that it has received KRW 6.893915 billion in funding from Prestige BioPharma Limited